Condition: HIV Infections · Antiretroviral Agents · Sponsor: University Hospital, Bordeaux
HIV infection is now a chronic disease in countries where antiretroviral treatments (ART) are largely available. Long-term follow-up is required to describe and understand the evolution of morbidities and complications as well as new treatments side effects. The main objective of the cohort is to describe and study the evolution of HIV infection in ART-treated individuals.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| service de médecine interne - CH d'Agen | Agen, France | — |
| Médecine interne - CH d'Angoulême | Angoulême, France | — |
| service de maladies infectieuses - CH de la Côte Basque | Bayonne, France | — |
| service de médecine inter et maladies infectieuses - Hopital Saint André | Bordeaux, France | — |
| service de médecine interne et maladies infectieuses - Hôpital Saint-André | Bordeaux, France | — |
| service de maladies infectieuses et médecine tropicale - Hôpital Pellegrin | Bordeaux, France | — |
| Service D'Urgences Pédiatriques | Bordeaux, France | — |
| service de médecine interne et maladies infectieuses - CH de Dax | Dax, France | — |
| Médecine Interne - CH de Jonzac | Jonzac, France | — |
| service de médecine interne - CH d'Arcachon | La Teste-de-Buch, France | — |
| service de médecine interne - CH de Libourne | Libourne, France | — |
| service de médecine interne - CH d'Orthez | Orthez, France | — |
+ 7 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.